17-Noratis-15-ene-13,14-dicarboxylicacid, 16-(1-methylethyl)-18-oxo-18-(1-piperazinyl)-, cyclic anhydride, (4a,8a,12a,13R,14R)- (9CI) (53471-69-5)

Identification
Name:	17-Noratis-15-ene-13,14-dicarboxylicacid, 16-(1-methylethyl)-18-oxo-18-(1-piperazinyl)-, cyclic anhydride, (4a,8a,12a,13R,14R)- (9CI)
Synonyms:	1H-3b,11-Ethenophenanthro[1,2-c]furan,17-noratis-15-ene-13,14-dicarboxylic acid deriv.
CAS:	53471-69-5
Molecular Formula:	C28H40 N2 O4
Molecular Weight:	468.6282
InChI:	InChI=1/C28H40N2O4/c1-16(2)18-15-28-9-6-19-26(3,20(28)14-17(18)21-22(28)24(32)34-23(21)31)7-5-8-27(19,4)25(33)30-12-10-29-11-13-30/h15-17,19-22,29H,5-14H2,1-4H3
Molecular Structure:
Properties
Flash Point:	338.8°C
Boiling Point:	636.6°C at 760 mmHg
Density:	1.22g/cm³
Refractive index:	1.587
Flash Point:	338.8°C
Safety Data

Other Product

17-Noratis-15-ene-13,14-dicarboxylicacid, 16-(1-methylethyl)-18-(4-morpholinyl)-18-oxo-, cyclic anhydride, (4a,8a,12a,13R,14R)- (9CI)
17-Noratis-15-ene-13,14-dicarboxylicacid, 18-[4-(2-hydroxyethyl)-1-piperazinyl]-16-(1-methylethyl)-18-oxo-, cyclicanhydride, (4a,8a,12a,13R,14R)- (9CI)
17,19-Dinoratis-15-ene-4,13,14-tricarboxylicacid, 16-(1-methylethyl)-, (4a,8a,12a,13R,14S)-
17,19-Dinoratis-15-ene-4,13,14-tricarboxylic acid, 16-(1-methylethyl)-, cyclic 13,14-anhydride, (4alpha,8alpha,12alpha,13R,14R)-, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol
dynorphin A (1-13), Tyr(14)-Leu(15)-Phe(16)-Asn(17)-Gly(18)-Pro(19)-
17-Norkaur-15-en-18-oicacid, 13-methyl-14-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-, (4a,8b,13b,14S)-
3'H-Cyclopenta[3,4]-18-norandrost-3-ene-3',13-dicarboxylicacid, tetrahydro-4'-hydroxy-4,5',5',9-tetramethyl-15-(1-methylethenyl)-, (3b,3'b,4a,4'a,5b,8a,9b,10a,13a,14b,15b)-
Kaur-16-en-18-oic acid,13-hydroxy-15-oxo-, (4a)- (9CI)
5'H-Cyclopenta[3,4]-18-norandrost-3-ene-9,13-dicarboxylicacid, 3,4-dihydro-15-hydroxy-4,5',5'-trimethyl-15-(1-methylethenyl)-, g-lactone, (3b,4a,5b,8a,9b,10a,13a,14b,15a)- (9CI)
Kaur-16-en-18-al,7,12,14-trihydroxy-15-oxo-, (4b,7a,12a,14R)-
13-(1-Methylethyl)-15-[(4bS,8aS)-4b,5,6,7,8,8a,9,10-octahydro-3-hydroxy-4b,8,8-trimethylphenanthren-2-yl]-17-noratis-13-ene-15β-carboxylic acid γ-lactone
(4α,8α,12α,13R,14R)-16-isopropyl-17,19-dinoratis-15-ene-4,13,14-tricarboxylic acid, cyclic 13,14-anhydride
1/C17H18OS/c1-4-11-7-5-8-12-13-9-6-10-14(17(2,3)18)16(13)19-15(11)12/h5-10,18H,4H2,1-3H
1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
(4R,8R,13R)-13-(Hydroxymethyl)-17-norkaur-15-ene-3α,18-diol
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
Atis-16-en-18-oic acid,7-[[(2Z)-2-methyl-1-oxo-2-buten-1-yl]oxy]-, (4a,5b,7b,8a,9b,10a,12a)-
1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H
1/C19H24N2O2/c1-12(2)14-8-6-9-15(13(3)4)17(14)21-19(22)18-16(23-5)10-7-11-20-18/h6-13H,1-5H3,(H,21,22